We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

29 hedge funds and large institutions have $7.04M invested in ImmuCell in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

4% more funds holding

Funds holding: 28 → 29 (+1)

0.23% more ownership

Funds ownership: 11.15% → 11.37% (+0.23%)

13% less capital invested

Capital invested by funds: $8.05M → $7.04M (-$1.01M)

44% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 9

Holders
29
Holders Change
+1
Holders Change %
+3.57%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
9
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$179K
2
HPC
HM Payson & Co
Maine
+$54.8K
3
Morgan Stanley
Morgan Stanley
New York
+$32.2K
4
BL
Bleichroeder LP
New York
+$14.7K
5
BlackRock
BlackRock
New York
+$5.97K

Top Sellers

Rank Fund Capital Flow
1
PCM
Perritt Capital Management
Illinois
-$89.3K
2
Renaissance Technologies
Renaissance Technologies
New York
-$77.8K
3
OMC
Overbrook Management Corp
New York
-$59.5K
4
OSAM
O'Shaughnessy Asset Management
Connecticut
-$14K
5
EFS
Essex Financial Services
Connecticut
-$11.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$1.34M -$77.8K -8,706 -5%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.34M +$179K +20,008 +14%
MFW
3
Meristem Family Wealth
Minnesota
$683K – – –
OMC
4
Overbrook Management Corp
New York
$604K -$59.5K -6,656 -8%
BL
5
Bleichroeder LP
New York
$498K +$14.7K +1,642 +3%
Morgan Stanley
6
Morgan Stanley
New York
$452K +$32.2K +3,599 +7%
PCM
7
Perritt Capital Management
Illinois
$320K -$89.3K -10,000 -20%
SFS
8
Strategic Financial Services
New York
$240K – – –
Geode Capital Management
9
Geode Capital Management
Massachusetts
$179K – – –
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$155K -$10K -1,121 -5%
HighTower Advisors
11
HighTower Advisors
Illinois
$146K – – –
SRC
12
Shufro Rose & Co
New York
$143K – – –
FHA
13
Flagship Harbor Advisors
Massachusetts
$134K -$8.94K -1,000 -6%
WE
14
Wealth Effects
Massachusetts
$127K +$142K +15,850 New
BlackRock
15
BlackRock
New York
$124K +$5.97K +668 +5%
PP
16
Prosperity Planning
Missouri
$120K – – –
Northern Trust
17
Northern Trust
Illinois
$106K -$2.04K -228 -2%
EFS
18
Essex Financial Services
Connecticut
$102K -$11.5K -1,282 -9%
MA
19
Minerva Advisors
Pennsylvania
$95K – – –
HPC
20
HM Payson & Co
Maine
$65K +$54.8K +6,130 +307%
Koshinski Asset Management
21
Koshinski Asset Management
Illinois
$19.2K -$4.47K -500 -17%
UBS Group
22
UBS Group
Switzerland
$19K – – –
Bank of America
23
Bank of America
North Carolina
$16K -$170 -19 -0.9%
US Bancorp
24
US Bancorp
Minnesota
$5K – – –
TCWM
25
Total Clarity Wealth Management
Illinois
$5K +$5.79K +648 New
1
2

ICCC Hedge Fund Activity: Q4 2021 in Review

29 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q4 2021, worth a combined $7.04M — down 13% from $8.05M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new ICCC positions and 2 closed out — a net gain of 1 holder — while 5 added to existing stakes and 9 trimmed.

The largest buyer was Vanguard Group, adding an estimated $179K. The largest seller was Perritt Capital Management, cutting an estimated $89.3K.

  • 29 institutional investors held ImmuCell (ICCC) as of Q4 2021, up from 28 in Q3 2021.
  • Funds reported $7.04M of ImmuCell stock for Q4 2021, down 13% quarter-over-quarter.
  • 3 funds opened new ImmuCell positions in Q4 2021 and 2 closed out, a net change of +1 holder.
  • The largest ImmuCell buyer in Q4 2021 was Vanguard Group, an estimated $179K added.
  • The largest ImmuCell seller in Q4 2021 was Perritt Capital Management, an estimated $89.3K sold.

Based on aggregated 13F filings for Q4 2021.